Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: South Korea Clear all

276 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20053
20066
20076
20088
200916
201012
201112
201212
201318
201415
201518
201612
201714
201815
201910
202013
202117
202216
202319
202410
202512
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed145
Unknown status40
Recruiting36
Terminated23
Active, not recruiting21
Not yet recruiting6
Withdrawn4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital57
Asan Medical Center18
AstraZeneca14
Bayer14
Samsung Medical Center13
Bristol-Myers Squibb11
Yonsei University11
CHA University6
Hoffmann-La Roche6
GC Cell Corporation5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular276
Liver Neoplasms46
Neoplasms18
Liver Cirrhosis12
Neoplasm Metastasis9
Carcinoma, Renal Cell8
Colorectal Neoplasms8
Carcinoma7
Carcinoma, Non-Small-Cell Lung7
Cholangiocarcinoma7

Trials

Showing 51 to 75 of 276. Each trial links to its page on Pharma Observatory.

176 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.